The global atrial fibrillation devices market is estimated to grow significantly at a CAGR of 13.7% during the forecast period. The growing prevalence of atrial fibrillation diseases is estimated to be one of the major factors that are driving the growth of the atrial fibrillation market across the globe. Atrial filtration is the most common arrhythmia with a prevalence of 1% to 2% in the population. The prevalence of atrial fibrillation is continuously rising owing to the increase in the geriatric population.
To Request a Sample of our Report on Atrial Fibrillation Devices Market: https://www.omrglobal.com/request-sample/atrial-fibrillation-devices-market
Atrial fibrillation is the major cause of stroke and accounts for 25% of acute ischemic strokes in patients with the age of more than 80 years of age as compared with 10% to 15% in all age groups. The stroke preventive strategies in patients along with atrial fibrillation and outcome have improved as a result of a reduction in the mortality and cost of acute ischemic stroke in atrial fibrillation patients. Electrophysiology enables in to identify the mechanism of a large QRS tachycardia, sites for AV node ablation and predisposing arrhythmia.
According to the Institute for Health Metrics and Evaluation, the prevalence of atrial fibrillation in 2013 was 33.6 million peoples, which increased to 37.5 million in 2017. Keeping the close look in the sedentary lifestyle of the people across the globe, this number is further expected to increase in the near future. This would augment the market growth of the global atrial fibrillation devices market.
Growing Inclination Towards Minimally Invasive Methods
There is a significant rise witnessed in the adoption of minimally invasive surgeries, which is supporting the use of innovative atrial fibrillation devices by considering efficacy and safety associated with the device. For instance, the non-invasive imaging of cardiac electrophysiology performed by the fusing data forms high- resolution electrocardiogram mapping with a model of patient’s individual cardiothoracic anatomy created from magnetic resonance imaging (MRI).
The less invasive imaging provides minimally invasive ventricular activation that can be essential for CRT patients to locate the area of the latest ventricular activation. With the advancement of minimally invasive pacemakers, implantable cardiac defibrillator and ablation catheters further raise the demand for minimally invasive electrophysiology methods that further propel the market growth.
(Get 15% Discount on Buying this Report)
A full Report of Atrial Fibrillation Devices Market is Available at: https://www.omrglobal.com/industry-reports/atrial-fibrillation-devices-market
Current Market Trends Covered in the Global Atrial Fibrillation Devices Market Report
- On the basis of the product type, the electrophysiology mapping and recording systems segment are estimated to hold a significant market share during the forecast period.
- Asia-Pacific is estimated to gain maximum traction in the global atrial fibrillation devices industry during the forecast period.
- Based on the end-use segment, the ambulatory surgery centers segment is estimated to foresee an optimistic growth rate over the forecast period.
Global Atrial Fibrillation Devices Market Segmentation
By Product Type
- Electrophysiology Ablation Catheters
- Electrophysiology Diagnostic Catheters
- Electrophysiology Mapping and Recording Systems
- Cardiac Monitors
- Others
By End-Use
- Hospitals
- Ambulatory Surgery Centers (ASCs)
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- Rest of APAC
Rest of The World
- Latin America
- Middle East and Africa
Company Profiles
- Abbott Laboratories Inc.
- AblaCor Medical Corp.
- AtriCure, Inc.
- Biomerics, LLC
- Biotronik, Inc.
- Boston Scientific Corp.
- CardioFocus, Inc.
- CathVision ApS
- General Electric Co.
- Integer Holdings Corp.
- Japan Lifeline Co., Ltd.
- Johnson & Johnson (Biosense Webster, Inc.)
- Koninklijke Philips N.V.
- Medtronic PLC
- Microport Scientific Corp.
- Millar, Inc.
- Molecular Devices, LLC
- Rhythmlink International, LLC
- Sanofi SA
- Stryker Corp.
- Transonic Systems, Inc.
Reasons to Buy From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/atrial-fibrillation-devices-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
